Pulseless electrical activity (PEA) is a clinical condition characterized by unresponsiveness and lack of palpable pulse in the presence of organized cardiac electrical activity and is caused by a profound cardiovascular insult (e.g., severe prolonged hypoxia or acidosis, extreme hypovolemia, or flow-restricting pulmonary embolus). Amyotrophic lateral sclerosis (ALS) is a disease that is characterized by progressive degeneration of all levels of the motor nervous system. Damage to the respiratory system and weakness of the muscles may increase the likelihood of an emergency situation occurring in patients with ALS while under general anesthesia. We report a case of PEA during the induction of general anesthesia in a patient with ALS who presented for dental treatment and discuss the causes of PEA and necessary considerations for general anesthesia in patients with ALS.
Pulseless electrical activity (PEA), also known as electromechanical dissociation, is a clinical condition characterized by unresponsiveness and lack of a palpable pulse in the presence of organized cardiac electrical activity [1] . PEA is found initially in about 55% of people in cardiac arrest and occurs when a major cardiovascular, respiratory, or metabolic derangement results in the inability of cardiac muscle to generate sufficient force in response to electrical depolarization. PEA is always caused by a profound cardiovascular insult (e.g., severe prolonged hypoxia or acidosis, extreme hypovolemia, or flow-restricting pulmonary embolus). The typical treatment approach is to initiate cardiopulmonary resuscitation (CPR) immediately and to identify and treat the underlying cause [1] [2] [3] .
Amyotrophic lateral sclerosis (ALS), also known as Lou
Gehrig's disease, is a disease that is characterized by progressive degeneration of all levels of the motor nervous system [4] . The progressive degeneration of motor neurons causes symptoms of muscular weakness, lack of coordination, atrophy, fasciculations, spasticity, and hyperreflexia. This results in progressive asymmetric limb weakness and bulbar symptoms such as dysarthria (difficulty in speaking), dysphagia (difficulty in swallowing), and eventually respiratory muscle weakness (difficulty in breathing) [5] [6] [7] . As ALS progresses, atrophy and weakness may affect most skeletal muscles, including the diaphragm, costal muscles, and those of the pharynx and larynx. This may lead to a decrease in general condition and a higher risk of aspiration pneumonia due to dysphagia, an exaggerated change in the response to muscle relaxants, and delayed recovery of spontaneous breathing after general anesthesia, among other adverse side effects. Therefore, when considering anesthetic management in patients with ALS, careful monitoring and appropriate drug selection is necessary because the likelihood of emergency situations occurring is higher than that in healthy patients [7, 8] .
We report a case of PEA developing during the induction of general anesthesia in a patient with ALS who presented for dental treatment, and discuss the causes of PEA and necessary considerations for general anesthesia in patients with ALS. to presentation, his dysphagia had become increasingly severe, resulting in aspiration pneumonia and admission.
After that, he was taking a sticky liquid meal. There was no sensory deficit on examination.
Oral examination revealed the presence of proximal caries in the maxillary right first, second, and third molar and second premolar, and generalized periodontitis ( Fig.   2A, B) . A treatment plan including extraction, root canal treatment, and periodontal treatment was established. We decided to proceed with dental treatment under general anesthesia in the outpatient unit because the risk of reflux and lung aspiration due to the patient's swallowing dysfunction was expected to be high.
The patient had a history of severe hypotension after propofol infusion during general anesthesia induction performed at this center 4 years ago. A 4-hour dental treatment was performed while under general anesthesia with stable vital signs after atropine and ephedrine administration. Pre-anesthesia blood test and chest X-ray results were normal.
On the day of treatment, the patient presented after 8 hours of fasting and entered the operating room without receiving premedication. The patient was placed in a supine position on the dental chair and electrocardiography (EKG), non-invasive blood pressure monitoring (NIBP), and pulse oximeter monitoring were performed.
An electroencephalogram (EEG)-entropy device (Entropy EasyFit Sensor disposable, Datex Ohmeda E-Entropy
Module, GE Healthcare, Finland) was attached to the forehead of the patient to determine the anesthetic induction procedure and intraoperative anesthetic depth.
The patient's initial vital signs were as follows: BP = 88/58 mmHg, heart rate = 82 beats/min, SpO 2 = 98%, and electrocardiogram was normal.
A face mask was used to administer 4 L/min oxygen and nitrous oxide gas. After the patient's loss of consciousness, an 18-gauge intravenous catheter was inserted into the right arm and Hartman solution was administered.
Next, 4% sevoflurane gas was added to maintain mmHg and the waveform as seen using the pulse oximeter was lost. In the EKG, sinus bradycardia (less than 40 beats/min) was persistent and the carotid pulse was lost. The end tidal CO2(ETCO2) dropped to 10 mmHg and our team diagnosed PEA (Fig. 3A, B) . Since PEA is a cardiac arrest, our team performed cardiopulmonary Table 1 . Treatment of cardiac arrest associated with neuraxial anesthesia [10] mediolateral nucleus (IML) of the upper thoracic spinal cord [12, 13] . Asai et al. [13] reported that patients with ALS had reduced sympathetic activity in the terminal stages of disease, presumably due to neuronal loss in the IML, which may increase risk of sudden cardiac arrest.
Oey et al. [14] investigated several aspects of autonomic function, such as muscle sympathetic nerve activity, vagal (baroreflex) control of heart rate, and cardiac function in patients with ALS and healthy volunteers. Patients with ALS had decreased spontaneous baroreflex sensitivity and reduced muscle sympathetic nerve activity [14] . Our patient also showed features of late ALS, such as asymmetric limb weakness and bulbar symptoms (e.g., dysarthria, dysphagia, and respiratory muscle weakness), and the initial blood pressure and heart rate were both very low. Therefore, sympathetic disturbances may have been related to the occurrence of PEA.
Because the sympathetic disturbance seen in patients with ALS is similar to that of neuraxial anesthesia, we performed ALS according to the cardiac arrest treatment guideline related to neuraxial anesthesia when PEA occurred. We discontinued sedation infusion and per- 
